Evaluation of a context-aware chatbot using retrieval-augmented generation for answering clinical questions on medication-related osteonecrosis of the jaw.

Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
PMID:

Abstract

The potential of large language models (LLMs) in medical applications is significant, and Retrieval-augmented generation (RAG) can address the weaknesses of these models in terms of data transparency and scientific accuracy by incorporating current scientific knowledge into responses. In this study, RAG and GPT-4 by OpenAI were applied to develop GuideGPT, a context aware chatbot integrated with a knowledge database from 449 scientific publications designed to provide answers on the prevention, diagnosis, and treatment of medication-related osteonecrosis of the jaw (MRONJ). A comparison was made with a generic LLM ("PureGPT") across 30 MRONJ-related questions. Ten international experts in MRONJ evaluated the responses based on content, language, scientific explanation, and agreement using 5-point Likert scales. Statistical analysis using the Mann-Whitney U test showed significantly better ratings for GuideGPT than PureGPT regarding content (p = 0.006), scientific explanation (p = 0.032), and agreement (p = 0.008), though not for language (p = 0.407). Thus, this study demonstrates RAG to be a promising tool to improve response quality and reliability of LLMs by incorporating domain-specific knowledge. This approach addresses the limitations of generic chatbots and can provide traceable and up-to-date responses essential for clinical practice.

Authors

  • David Steybe
    Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU Munich, Munich, Germany. Electronic address: david.steybe@med.uni-muenchen.de.
  • Philipp Poxleitner
    Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU Munich, Munich, Germany.
  • Suad Aljohani
    Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU Munich, Munich, Germany; Department of Oral Diagnostic Sciences, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Bente Brokstad Herlofson
    Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo and Department of Otorhinolaryngology - Head and Neck Surgery Division for Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway.
  • Ourania Nicolatou-Galitis
    Oncology Patient Support Company PC, CureCancer - mycancer.gr, Athens, Greece.
  • Vinod Patel
    Department of Oral Surgery, Guy's and St Thomas' Hospital, London, United Kingdom.
  • Stefano Fedele
    UCL Eastman Dental Institute and NIHR UCLH Biomedical Research Centre, University College London, United Kingdom.
  • Tae-Geon Kwon
    Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook National University, Daegu, South Korea.
  • Vittorio Fusco
    Oncology Unit, Department of Medicine and Translational Medicine Unit, DAIRI - Department of Integration, Research and Innovation, "SS Antonio e Biagio e C.Arrigo" Hospital, Alessandria, Italy.
  • Sarina E C Pichardo
    Department of Oral & Maxillofacial Surgery, University Medical Center Groningen, Groningen, the Netherlands.
  • Katharina Theresa Obermeier
    Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU Munich, Munich, Germany.
  • Sven Otto
    Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU Munich, Munich, Germany.
  • Alexander Rau
    Department of Neuroradiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Maximilian Frederik Russe
    Department of Diagnostic and Interventional Radiology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.